Bahrain: Covishield vaccine interval extended to 8 weeks

Bahrain: Covishield vaccine interval extended to 8 weeks

Following recommendations from the WHO, Covishield-AstraZeneca dosing intervals have been extended from 4 to 8 weeks.



To increase vaccine efficiency and produce a strong immune response.

Comments





Read Next

4 hours ago

Bahrain opens Covid vaccine registration for pregnant women

20 hours ago

Bahrain reports 637 new Covid-19 cases, 2 deaths

2 days ago

Bahrain records 653 new coronavirus cases, 4 deaths

2 days ago

Bahrain: 675 new cases detected out of 13,232 tests

3 days ago

One year of the coronavirus pandemic in Bahrain

3 days ago

Dubai approves longer interval between vaccine doses

3 days ago

Bahrain records 721 new cases and 6 deaths

4 days ago

Bahrain: 575 new coronavirus cases detected

5 days ago

Bahrain records 752 new coronavirus cases, 2 deaths

6 days ago

Study: AstraZeneca more effective with longer dose gap